Allena Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Newton, Massachusetts, focused on the research, development, and commercialization of orally administered enzyme therapeutics for rare and severe metabolic and kidney disorders.
Subscribe to see Allena Pharmaceuticals’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Allena Pharmaceuticals is a biopharmaceuticals company headquartered in United States. It has raised at least $70.5M across the 3 funding rounds on record. Its most recent funding round raised $4.1M in May 2022. Xcout tracks 3 named people at Allena Pharmaceuticals, including Bob Goodman (Firm Management).
At least $70.5M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $4.1M | — | |
| SEC Form D filing | $51.4M | — | |
| Series A | $15M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.